UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000500
Receipt number R000000605
Scientific Title Availability of percutaneous needle washing for the diagnosis of pulmonary thin-walled cavitary lesions filled with air.
Date of disclosure of the study information 2006/10/10
Last modified on 2007/08/12 20:30:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Availability of percutaneous needle washing for the diagnosis of pulmonary thin-walled cavitary lesions filled with air.

Acronym

Availability of percutaneous needle washing for the diagnosis of pulmonary thin-walled cavitary lesions filled with air.

Scientific Title

Availability of percutaneous needle washing for the diagnosis of pulmonary thin-walled cavitary lesions filled with air.

Scientific Title:Acronym

Availability of percutaneous needle washing for the diagnosis of pulmonary thin-walled cavitary lesions filled with air.

Region

Japan


Condition

Condition

Pulmonary thin-walled cavitary lesions filled with air

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Sputum examination and the bronchoscopic technique may be performed in an attempt to diagnose pulmonary thin-walled cavitary lesions. However, in our experience, a diagnosis cannot always be established in these lesions by sputum examination or the bronchoscopic technique, and surgical biopsy is occasionally needed, which is a highly invasive method. Millard and Westcott reported a method of percutaneous needle washing for the diagnosis of cavitary lesions of the lung, in which normal saline is injected into the cavity and then aspirated (Radiology 1974;111:474). We aim to ascertain the diagnostic significance and the safety of percutaneous needle washing method in the diagnosis of pulmonary thin-walled cavitary lesions.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

The specimen obtained by percutaneous needle washing method is analyzed by cytological and microbiological examinations. Sensitivity and specificity of this method in the diagnosis of pulmonary thin-walled cavitary lesions is observed. The final diagnosis of each patient is confirmed by either surgery or clinical follow-up of more than one year.

Key secondary outcomes

The clinical observation of more than one year after the procedure for each patient is required to monitor the potential complications of percutaneous needle washing method; short-term complications (pneumothorax, hemoptysis, cough, air embolism, etc.) and long-term complications (invasion of the cancer, spread of the infection, etc.).


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Percutaneous needle washing is performed for pulmonary thin-walled cavitary lesions whose diagnosis can not be established by sputum examination or bronchoscopic procedures.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with pulmonary thin-walled cavitary lesions whose diagnosis can not be established by sputum examination or bronchoscopic procedures.

Key exclusion criteria

Patients with bleeding tendency or allergy to local anesthetics. Patients who do not give informed consent to participate in the study.

Target sample size

25


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuharu Nakahara

Organization

National Hospital Organization, Himeji Medical Center

Division name

Respiratory Medicine

Zip code


Address

Honmachi 68, Himeji-city 670-8520 Japan

TEL

079-225-3211

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yasuharu Nakahara

Organization

National Hospital Organization, Himeji Medical Center

Division name

Respiratory Medicine

Zip code


Address

Honmachi 68, Himeji-city 670-8520 Japan

TEL

079-225-3211

Homepage URL


Email

nakahary@hmj-net.hosp.go.jp


Sponsor or person

Institute

Department of Respiratory Medicine, National Hospital Organization, Himeji Medical Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2006 Year 10 Month 10 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Published in Intern Med. 2007;46(14):1089-94

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2000 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2000 Year 09 Month 01 Day

Last follow-up date

2006 Year 09 Month 01 Day

Date of closure to data entry

2006 Year 10 Month 01 Day

Date trial data considered complete

2006 Year 10 Month 01 Day

Date analysis concluded

2006 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2006 Year 10 Month 09 Day

Last modified on

2007 Year 08 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000605


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name